Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

The HIV Prevention Trials Network (HPTN) 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was more effective than tenofovir disoproxil fumarate-emtricitabine (TDF/FTC) in preventing human immunodeficiency virus (HIV) in cisgender men and transgender women who have sex with men. We chara...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The Journal of infectious diseases Ročník 224; číslo 9; s. 1581
Hlavní autoři:	Marzinke, Mark A, Grinsztejn, Beatriz, Fogel, Jessica M, Piwowar-Manning, Estelle, Li, Maoji, Weng, Lei, McCauley, Marybeth, Cummings, Vanessa, Ahmed, Shahnaz, Haines, Casey D, Bushman, Lane R, Petropoulos, Christos, Persaud, Deborah, Adeyeye, Adeola, Kofron, Ryan, Rinehart, Alex, St Clair, Marty, Rooney, James F, Pryluka, Daniel, Coelho, Lara, Gaur, Aditya, Middelkoop, Keren, Phanuphak, Nittaya, Cohen, Myron S, Hendrix, Craig W, Anderson, Peter, Hanscom, Brett, Donnell, Deborah, Landovitz, Raphael J, Eshleman, Susan H
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 16.11.2021
Témata:	Adolescent Adult Anti-HIV Agents - administration & dosage Diketopiperazines - administration & dosage Female HIV Infections - epidemiology HIV Infections - prevention & control HIV Integrase Inhibitors - administration & dosage Homosexuality, Male Humans Incidence Male Middle Aged Pre-Exposure Prophylaxis Pyridones - administration & dosage Retrospective Studies Transgender Persons Viral Load - drug effects injectable HIV preexposure prophylaxis HPTN 083 TDF/FTC cabotegravir long-acting men who have sex with men prevention
ISSN:	1537-6613, 1537-6613
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!